INTERNATIONAL PATENT: NOVARTIS AG FILES APPLICATION FOR "KRAS G12C INHIBITOR FOR USE FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER"

GENEVA, Oct. 4 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/053263) for "KRAS G12C INHIBITOR FOR USE FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER" on Mar 27, 2025. With publication no. WO/2025/202971, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BITTON, Rafael Caparica (Novartis Pharma AGLichtstrasse 354056 Basel), CUI, Xiaoming (Novartis Pharmaceuticals Corporation59 Route 10East Hanover, New Jersey 07936), LOBETTI BODONI, Chiara (Novartis Pharma AGLichtstrasse 354056 Basel), YO...